Company News
UBS Upgrades Straumann to Buy, CHF115 Target
UBS upgrades Swiss dental group Straumann to "Buy" from "Neutral", ending a five‑year cautious stance.
UBS raises the 12‑month price target to CHF 115 from CHF 90, implying roughly 23% upside from the
